Eli Lilly and Company (LLY) stock analysis

In our weekly check, Eli Lilly and Company is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 22 pass, warnings: 2, red flags: 1.

About Eli Lilly and Company

Eli Lilly and Company is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as LLY.

What our checks show for LLY

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-03

Similar companies

NVO · MRK · ABBV · PFE · JNJ · AZN

Questions

What grade does Eli Lilly and Company (LLY) have?

In our weekly check, Eli Lilly and Company is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 22 pass, warnings: 2, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of LLY stock?

This week's biggest flags for Eli Lilly and Company: Slow recovery after falls, High debt, Deep past fall. In total 3 of 25 checks show a warning or a red flag.

What does Eli Lilly and Company do?

Eli Lilly and Company is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as LLY.

When does Eli Lilly and Company report earnings next?

The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis